IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RAVAGGI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.909
EU - Europa 3.077
AS - Asia 2.969
SA - Sud America 473
Continente sconosciuto - Info sul continente non disponibili 220
AF - Africa 70
OC - Oceania 10
AN - Antartide 1
Totale 14.729
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.629
CN - Cina 997
SG - Singapore 956
PL - Polonia 595
DE - Germania 524
IT - Italia 470
UA - Ucraina 430
BR - Brasile 394
HK - Hong Kong 324
GB - Regno Unito 262
FI - Finlandia 224
VN - Vietnam 206
CA - Canada 163
FR - Francia 135
BD - Bangladesh 100
TR - Turchia 99
RU - Federazione Russa 96
IE - Irlanda 87
IN - India 87
EE - Estonia 47
SE - Svezia 42
MX - Messico 39
NL - Olanda 38
ID - Indonesia 34
AR - Argentina 31
IQ - Iraq 28
ZA - Sudafrica 27
ES - Italia 25
JP - Giappone 19
LT - Lituania 19
AT - Austria 17
BE - Belgio 17
CR - Costa Rica 15
CZ - Repubblica Ceca 14
EC - Ecuador 14
HN - Honduras 13
MA - Marocco 12
KG - Kirghizistan 11
AE - Emirati Arabi Uniti 10
PK - Pakistan 10
VE - Venezuela 10
EU - Europa 9
SA - Arabia Saudita 9
AU - Australia 8
KR - Corea 8
BG - Bulgaria 7
TT - Trinidad e Tobago 7
TW - Taiwan 7
UZ - Uzbekistan 7
CO - Colombia 6
GT - Guatemala 6
JM - Giamaica 6
JO - Giordania 6
MY - Malesia 6
NG - Nigeria 6
NP - Nepal 6
SV - El Salvador 6
CL - Cile 5
GP - Guadalupe 5
IL - Israele 5
NI - Nicaragua 5
TN - Tunisia 5
CW - ???statistics.table.value.countryCode.CW??? 4
EG - Egitto 4
IR - Iran 4
KE - Kenya 4
KZ - Kazakistan 4
LK - Sri Lanka 4
LV - Lettonia 4
MU - Mauritius 4
PH - Filippine 4
PT - Portogallo 4
PY - Paraguay 4
AL - Albania 3
AZ - Azerbaigian 3
BB - Barbados 3
BO - Bolivia 3
BY - Bielorussia 3
PA - Panama 3
PE - Perù 3
PR - Porto Rico 3
RO - Romania 3
TH - Thailandia 3
UY - Uruguay 3
AG - Antigua e Barbuda 2
BH - Bahrain 2
BN - Brunei Darussalam 2
CH - Svizzera 2
ET - Etiopia 2
LC - Santa Lucia 2
LU - Lussemburgo 2
OM - Oman 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
BS - Bahamas 1
BW - Botswana 1
DK - Danimarca 1
Totale 14.508
Salva come PNG Salva come JPEG
Città #
Ashburn 753
Fairfield 744
Warsaw 591
Woodbridge 563
Singapore 556
San Jose 429
Houston 398
Seattle 335
Jacksonville 309
Hong Kong 302
Chandler 292
Wilmington 263
Ann Arbor 256
Cambridge 250
New York 227
Beijing 207
Council Bluffs 207
The Dalles 174
Dearborn 161
Munich 158
Los Angeles 155
Helsinki 150
Princeton 149
Nanjing 102
Dublin 87
Brescia 83
Mcallen 83
Istanbul 75
Lauterbourg 73
Columbus 61
Des Moines 59
Shanghai 58
Ho Chi Minh City 57
Dallas 55
São Paulo 54
Milan 52
Buffalo 49
Santa Clara 48
San Francisco 47
Tallinn 46
Toronto 46
Chicago 43
Nanchang 42
Montréal 39
Shenyang 37
Dong Ket 36
Moscow 36
Hanoi 35
London 35
Jinan 33
San Diego 33
Montreal 30
Orem 28
Phoenix 27
Redondo Beach 27
Hebei 26
Changsha 25
Jiaxing 24
Kunming 24
Rome 24
Tianjin 24
Denver 23
Chennai 21
Jakarta 19
Turku 18
Guangzhou 17
Hangzhou 17
Mexico City 17
North Bergen 17
Johannesburg 16
Tokyo 16
Brussels 14
Nuremberg 14
Zhengzhou 14
Belo Horizonte 13
Brooklyn 13
Central 13
Manchester 13
Monmouth Junction 13
Paris 13
Poplar 13
Stockholm 13
Vienna 12
Amsterdam 11
Boston 11
Charlotte 11
Hefei 11
Mumbai 11
Rio de Janeiro 11
San José 11
Bishkek 10
Miami 10
Atlanta 9
Da Nang 9
Lancaster 9
Ningbo 9
Norwalk 9
Verona 9
Ankara 8
Lanzhou 8
Totale 9.898
Salva come PNG Salva come JPEG
Nome #
Influence of maternal CD4+ levels on the predictive value of virus load mother-to-child transmission of HIV type 1 (HIV-1) 436
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2916-21. doi: 10.1073/pnas.1222577110. Epub 2013 Jan 28. Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Zhao S1, Choi M, Overton JD, Bellone S, Roque DM, Cocco E, Guzzo F, English DP, Varughese J, Gasparrini S, Bortolomai I, Buza N, Hui P, Abu-Khalaf M, Ravaggi A, Bignotti E, Bandiera E, Romani C, Todeschini P, Tassi R, Zanotti L, Carrara L, Pecorelli S, Silasi DA, Ratner E, Azodi M, Schwartz PE, Rutherford TJ, Stiegler AL, Mane S, Boggon TJ, Schlessinger J, Lifton RP, Santin AD 375
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 374
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients. 344
Claudin3 is localized outside the tight junctions in human carcinomas 307
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 303
A prognostic regulatory pathway in stage I epithelial ovarian cancer: New hints for the poor prognosis assessment 240
Cancer antigen 125, human epididymis 4, kallikrein 6, osteopontin and soluble mesothelin-related peptide immunocomplexed with immunoglobulin M in epithelial ovarian cancer diagnosis. 230
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 227
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 224
Class III β-tubulin overexpression in ovarian clear cell and serous carcinoma as a maker for poor overall survival after platinum/taxane chemotherapy and sensitivity to patupilone 220
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 216
Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts 216
FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients 212
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 211
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 210
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma 209
Gene expression profiling to improve prognostic characterization of olfactory neuroblastoma and to define new targetable pathways 204
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial 202
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 200
Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma 200
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 197
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 195
DEVELOPMENT AND THERAPEUTIC EFFECT OF ADOPTIVELY TRANSFERRED T CELLS PRIMED BY TUMOR LYSATE-PULSED AUTOLOGOUS DENDRITIC CELLS IN A PATIENT WITH METASTATIC ENDOMETRIAL CANCER. 190
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 188
Development and characterization of a human single-chain antibody fragment against claudin-3: a novel therapeutic target in ovarian and uterine carcinomas. 187
RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients 186
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 186
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 185
Serum human epididymis protein 4 and risk for ovarian malignancy algorithm as new diagnostic and prognostic tools for epithelial ovarian cancer management. 183
Mutational landscape of uterine and ovarian carcinosarcomas implicates histone genes in epithelial-mesenchymal transition 180
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 178
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 178
Mammaglobin B expression in human endometrial cancer 177
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 174
TUMOR-INFILTRATING LYMPHOCYTES CONTAIN HIGHER NUMBERS OF TYPE 1 CYTOKINE EXPRESSORS AND DR+ T CELLS COMPARED WITH LYMPHOCYTES FROM TUMOR DRAINING LYMPH NODES AND PERIPHERAL BLOOD IN PATIENTS WITH CANCER OF THE UTERINE CERVIX. 168
Functional characterization of epithelial ovarian cancer histotypes by drug target based protein signaling activation mapping: Implications for personalized cancer therapy 168
MiRNA landscape in stage I epithelial ovarian cancer defines the histotype specificities. 165
Claudin 7 downregulation is predictive of distant metastasis in high-grade serous carcinoma patients 162
The claudin-low subtype of high-grade serous ovarian carcinoma exhibits stem cell features 161
IN VITRO INDUCTION OF TUMOR-SPECIFIC HUMAN LYMPHOCYTE ANTIGEN CLASS I-RESTRICTED CD8 CYTOTOXIC T LYMPHOCYTES BY OVARIAN TUMOR ANTIGEN-PULSED AUTOLOGOUS DENDRITIC CELLS FROM PATIENTS WITH ADVANCED OVARIAN CANCER. 159
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 159
INDUCTION OF OVARIAN TUMOR-SPECIFIC CD CYTOTOXIC T LYMPHOCYTES BY ACID-ELUTED PEPTIDE-PULSED AUTOLOGOUS DENDRITIC CELLS 157
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 156
Claudin-7 expression in human epithelial ovarian cancer 155
EXPRESSION PATTERN AND MOLECULAR FUNCTION OF TRASCRIPTION FACTOR FOXM1 (FORKHEAD BOX PROTEIN M1) IN EPITHELIAL OVARIAN CANCER CLINICAL SPECIMENS AND CELL LINES 154
Kinase-driven metabolic signalling as a predictor of response to carboplatin-paclitaxel adjuvant treatment in advanced ovarian cancers 154
Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer 153
Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients 153
Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways 152
Expression profiles of PRKG1, SDF2L1 and PPP1R12A are predictive and prognostic factors for therapy response and survival in high-grade serous ovarian cancer 151
Gene expression profiling of olfactory neuroblastoma helps identify prognostic pathways and define potentially therapeutic targets 151
Polymerase ε (POLE) ultra-mutation in uterine tumors correlates with T lymphocyte infiltration and increased resistance to platinum-based chemotherapy in vitro 150
INCREASED LEVELS OF INTERLEUKIN-10 AND TRANSFORMING GROWTH FACTOR-BETA IN THE PLASMA AND ASCITIC FLUID OF PATIENTS WITH ADVANCED OVARIAN CANCER. 149
LncRNAs as novel indicators of patients' prognosis in stage i epithelial ovarian cancer: A retrospective and multicentric study 142
Human papillomavirus type 16 and 18 E7-pulsed dendritic cell vaccination of stage IB or IIA cervical cancer patients: a phase I escalating-dose trial. 139
Quantification of hepatitis C virus RNA by competitive amplification of RNA from denatured serum and hybridization on microtiter plates 137
PHENOTYPIC AND FUNCTIONAL ANALYSIS OF TUMOR-INFILTRATING LYMPHOCYTES COMPARED WITH TUMOR-ASSOCIATED LYMPHOCYTES FROM ASCITIC FLUID AND PERIPHERAL BLOOD LYMPHOCYTES IN PATIENTS WITH ADVANCED OVARIAN CANCER. 137
Radiation-Enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma 134
Genetic evolution of the hypervariable region 1 in hetpatitis C virus carriers with normal aminotransferase activities 133
DEVELOPMENT, CHARACTERIZATION AND DISTRIBUTION OF ADOPTIVELY TRANSFERRED PERIPHERAL BLOOD LYMPHOCYTES PRIMED BY HUMAN PAPILLOMAVIRUS 18 E7--PULSED AUTOLOGOUS DENDRITIC CELLS IN A PATIENT WITH METASTATIC ADENOCARCINOMA OF THE UTERINE CERVIX. 132
Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients 131
FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients 127
Integrated mutational landscape analysis of uterine leiomyosarcomas 126
Human kallikrein 5: an interesting novel biomarker in ovarian cancer patients that elicits humoral response. 126
Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology. 124
L1CAM expression as a predictor of platinum response in high-risk endometrial carcinoma 122
Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma 121
Identical TP53 mutations in pelvic carcinosarcomas and associated serous tubal intraepithelial carcinomas provide evidence of their clonal relationship 121
EXPRESSION OF CD56 BY HUMAN PAPILLOMAVIRUS E7-SPECIFIC CD8+ CYTOTOXIC T LYMPHOCYTES CORRELATES WITH INCREASED INTRACELLULAR PERFORIN EXPRESSION AND ENHANCED CYTOTOXICITY AGAINST HLA-A2-MATCHED CERVICAL TUMOR CELLS. 115
HE4 and epithelial ovarian cancer : Comparison and clinical evaluation of two immunoassays and a combination algorithm 114
Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 114
The Oxford Classic can identify HGSOC patients who may benefit from EMT-targeting therapies 111
Correction for Li et al., Mutational landscape of primary, metastatic, and recurrent ovarian cancer reveals c-MYC gains as potential target for BET inhibitors 106
Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes 104
Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid Carcinoma: Implications for Immunotherapy With hRS7, a Humanized Anti-Trop-2 Monoclonal Antibody 102
Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer 102
Whole-exome sequencing of cervical carcinomas identifies activating ERBB2 and PIK3CA mutations as targets for combination therapy 99
Circulating Serum Micro-RNA as Non-Invasive Diagnostic Biomarkers of Endometriosis 97
Serum S100A6 concentration predicts peritoneal tumor burden inmice with epithelial ovarian cancer and is associated with advanced stage in patients. 94
Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study 92
Finding the junction between claudins and endometrial carcinoma 91
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: A retrospective study 79
Oxford Classic-Defined EMT Risk Stratification of High-Grade Serous Ovarian Cancer for Guiding Treatment Decisions 77
HE4, CA125 and risk of ovarian malignancy algorithm (ROMA) as diagnostic tools for ovarian cancer in patients with a pelvic mass: An Italian multicenter study 75
Development of a diagnostic model based on serum microRNAs for the diagnosis of endometriosis 69
PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine 68
Mammaglobin B (SCGB2A1) is a novel tumor antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy 58
VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients 54
Serum miRNA-based diagnostic models for endometriosis: from discovery to validation 35
Totale 14.729
Salva come PNG Salva come JPEG
Categoria #
all - tutte 64.293
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.293
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022548 0 0 0 15 5 48 49 39 32 132 64 164
2022/2023791 130 40 37 51 64 173 10 89 113 9 41 34
2023/2024956 49 32 93 86 47 221 53 49 163 51 15 97
2024/20251.692 18 46 21 281 147 171 104 62 165 103 356 218
2025/20263.732 374 346 255 529 439 290 579 129 235 336 137 83
2026/20271.048 164 150 229 505 0 0 0 0 0 0 0 0
Totale 14.729